Form 4: Brown-Forman EVP Granted Stock Appreciation Rights Under 10b5-1 Plan

Brown-Forman Corp's EVP, Chief Strategy, Christina M. Graven, was granted 22,532 Stock Appreciation Rights (SARs) effective July 24, 2025, under a pre-arranged Rule 10b5-1 plan.

Summary

• Christina M. Graven, Executive Vice President and Chief Strategy of Brown-Forman Corp (BFA, BFB), was granted 22,532 Stock Appreciation Rights (SARs).
• The transaction is effective July 24, 2025, and was made pursuant to a Rule 10b5-1(c) plan.
• Each SAR has an exercise price of $31.15.
• The SARs become exercisable on May 1, 2028, and expire on April 30, 2035.
• Following this reported transaction, Christina M. Graven beneficially owns 22,532 SARs directly.

Sentiment

Score: 7

Explanation: The grant of Stock Appreciation Rights to a key executive is a positive sign of continued alignment between management and shareholder interests, and a standard component of executive compensation executed under a transparent 10b5-1 plan.

Positives

• The grant of Stock Appreciation Rights aligns executive compensation with the company's performance and shareholder value creation.
• The transaction being executed under a Rule 10b5-1 plan indicates a pre-scheduled, non-discretionary compensation event, reducing concerns about opportunistic timing.

Future Outlook

The filing details a future grant of Stock Appreciation Rights to an executive, indicating a long-term incentive structure that aligns with future company performance.

Industry Context

This executive compensation grant is a standard practice within the consumer staples and beverage industry, aiming to incentivize long-term performance and align management interests with shareholder returns.

Comparison to Industry Standards

• The grant of Stock Appreciation Rights (SARs) is a common equity-based compensation tool used across various industries, including consumer goods, similar to grants by companies like Diageo plc or Constellation Brands, Inc.
• The use of a Rule 10b5-1 plan for such grants is a standard corporate governance practice to manage insider trading compliance and provide transparency for pre-planned transactions.

Stakeholder Impact

• Shareholders: The grant of SARs aligns the executive's financial interests with the company's stock performance, potentially benefiting shareholders through improved long-term strategic execution. There is a potential for future dilution if the SARs are settled in shares, but this is a standard aspect of equity compensation.

Next Steps

• The Stock Appreciation Rights will become exercisable on May 1, 2028.

Key Dates

Recommendation

This Form 4 reports a routine grant of Stock Appreciation Rights to an executive under a pre-arranged plan, which is a standard component of compensation and does not provide new information warranting a change in investment recommendation.

Keywords

Brown-Forman, BFA, BFB, SEC Form 4, insider transaction, stock appreciation rights, SARs, executive compensation, Rule 10b5-1 plan